 | • レポートコード：20QY06-04326 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、リラグルチドのグローバル市場について種類別（丸薬、液体）、用途別（病院、ドラッグストア）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・リラグルチド市場の概要 ・世界の主要地域別リラグルチド市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のリラグルチド市場規模2015-2026：種類別（丸薬、液体） ・世界のリラグルチド市場規模2015-2026：用途別（病院、ドラッグストア） ・リラグルチドの北米市場規模2015-2020 ・リラグルチドのヨーロッパ市場規模2015-2020 ・リラグルチドの中国市場規模2015-2020 ・リラグルチドの日本市場規模2015-2020 ・リラグルチドの東南アジア市場規模2015-2020 ・リラグルチドのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （HEC Pharm、Bachem、Bharat Pharmaceuticals、Kingpep Biotechnology、Shenzhen JYMed Technology、Wuxi Asiapeptide、AmbioPharm） ・リラグルチドの製造コスト分析 ・販売チャネル、流通業者、顧客 ・リラグルチドの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Liraglutide Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Liraglutide market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Liraglutide market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Liraglutide industry.
Based on our recent survey, we have several different scenarios about the Liraglutide YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Liraglutide will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Liraglutide market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Liraglutide market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Liraglutide market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Liraglutide market. The report also includes nautical information, where it shows Liraglutide market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Liraglutide market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Liraglutide market.
The total amount of Patents about Liraglutide are 1871, among those Patents, 44%is about application, 26%is about Combination therapy, and 12%is about Preparation method.
In these patents, accounting for Europe is the largest, followed by North America, and finally Asia.
The application of Liraglutide
Liraglutide for the treatment of type 2 diabetes mellitus
Liraglutide 1.2 mg daily in triple therapy regimens (in combination with metformin and a sulphonylurea, or metformin and a thiazolidinedione) is recommended as an option for the treatment of people with type 2 diabetes, only if used as described for exenatide in ‘Type 2 diabetes: the management of type 2 diabetes’
Liraglutide 1.2 mg daily in dual therapy regimens (in combination with metformin or a sulphonylurea) is recommended as an option for the treatment of people with type 2 diabetes, only if the person is intolerant of either metformin or a sulphonylurea, or treatment with metformin or a sulphonylurea is contraindicated, and the person is intolerant of thiazolidinediones and dipeptidyl peptidase-4 (DPP-4) inhibitors, or treatment with thiazolidinediones and DPP-4 inhibitors is contraindicated.
Liraglutide 1.8 mg daily is not recommended for the treatment of people with type 2 diabetes.
The Committee concluded that the evidence provided was not robust enough to allow it to recommend liraglutide as a cost-effective alternative to either thiazolidinediones or DPP-4 inhibitors as a triple therapy regimen, however it believes liraglutide is a cost-effective treatment option relative to exenatide.
Taking into account the lack of clinical trial evidence showing a significant benefit from increasing the liraglutide dose from 1.2 mg to 1.8 mg, the widely varying ICERs and the uncertainty in the economic analysis, the Committee was unable to recommend liraglutide 1.8 mg for the treatment of type 2 diabetes.
The Committee concluded that people with type 2 diabetes currently receiving liraglutide who do not meet the criteria specified in section 1.1 or 1.3, or who are receiving liraglutide 1.8 mg, should have the option to continue their current treatment until they and their clinicians consider it appropriate to stop.
Geographical Analysis:
Based on region, the global Liraglutide market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Liraglutide market are
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm
…
Segment by Type
Pills
Liquid
Segment by Application
Hospital
Drug Store
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Liraglutide market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Liraglutide market.
• The market share of the global Liraglutide market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Liraglutide market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Liraglutide market.
1 Liraglutide Market Overview
1.1 Liraglutide Product Scope
1.2 Liraglutide Segment by Type
1.2.1 Global Liraglutide Sales by Type (2020-2026)
1.2.2 Pills
1.2.3 Liquid
1.3 Liraglutide Segment by Application
1.3.1 Global Liraglutide Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Liraglutide Market Estimates and Forecasts (2015-2026)
1.4.1 Global Liraglutide Sales Growth Rate (2015-2026)
1.4.2 Global Liraglutide Revenue and Growth Rate (2015-2026)
1.4.3 Global Liraglutide Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Liraglutide Industry Impact
1.5.1 How the Covid-19 is Affecting the Liraglutide Industry
1.5.1.1 Liraglutide Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Liraglutide Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Liraglutide Players to Combat Covid-19 Impact
2 Liraglutide Estimate and Forecast by Region
2.1 Global Liraglutide Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Liraglutide Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Liraglutide Sales Market Share by Region (2015-2020)
2.2.2 Global Liraglutide Revenue Market Share by Region (2015-2020)
2.3 Global Liraglutide Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Liraglutide Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Liraglutide Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Liraglutide Estimates and Projections (2015-2026)
2.4.2 Europe Liraglutide Estimates and Projections (2015-2026)
2.4.3 China Liraglutide Estimates and Projections (2015-2026)
2.4.4 Japan Liraglutide Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Liraglutide Estimates and Projections (2015-2026)
2.4.6 India Liraglutide Estimates and Projections (2015-2026)
3 Global Liraglutide Competition Landscape by Players
3.1 Global Top Liraglutide Players by Sales (2015-2020)
3.2 Global Top Liraglutide Players by Revenue (2015-2020)
3.3 Global Liraglutide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liraglutide as of 2019)
3.4 Global Liraglutide Average Price by Company (2015-2020)
3.5 Manufacturers Liraglutide Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Liraglutide Players (Opinion Leaders)
4 Global Liraglutide Market Size by Type
4.1 Global Liraglutide Historic Market Review by Type (2015-2020)
4.1.1 Global Liraglutide Sales Market Share by Type (2015-2020)
4.1.2 Global Liraglutide Revenue Market Share by Type (2015-2020)
4.1.3 Global Liraglutide Price by Type (2014-2020)
4.2 Global Liraglutide Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Liraglutide Sales Forecast by Type (2021-2026)
4.2.2 Global Liraglutide Revenue Forecast by Type (2021-2026)
4.2.3 Global Liraglutide Price Forecast by Type (2021-2026)
5 Global Liraglutide Market Size by Application
5.1 Global Liraglutide Historic Market Review by Application (2015-2020)
5.1.1 Global Liraglutide Sales Market Share by Application (2015-2020)
5.1.2 Global Liraglutide Revenue Market Share by Application (2015-2020)
5.1.3 Global Liraglutide Price by Application (2015-2020)
5.2 Global Liraglutide Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Liraglutide Sales Forecast by Application (2021-2026)
5.2.2 Global Liraglutide Revenue Forecast by Application (2021-2026)
5.2.3 Global Liraglutide Price Forecast by Application (2021-2026)
3 North America Liraglutide Market Facts & Figures
3.2 North America Liraglutide Sales Market Share by Company (2015-2020)
3.3 North America Liraglutide Sales Market Share by Type (2015-2020)
3.4 North America Liraglutide Sales Market Share by Application (2015-2020)
4 Europe Liraglutide Market Facts & Figures
4.2 Europe Liraglutide Sales Market Share by Company (2015-2020)
4.3 Europe Liraglutide Sales Market Share by Type (2015-2020)
4.4 Europe Liraglutide Sales Market Share by Application (2015-2020)
5 China Liraglutide Market Facts & Figures
5.2 China Liraglutide Sales Market Share by Company (2015-2020)
5.3 China Liraglutide Sales Market Share by Type (2015-2020)
5.4 China Liraglutide Sales Market Share by Application (2015-2020)
6 Japan Liraglutide Market Facts & Figures
6.2 Japan Liraglutide Sales Market Share by Company (2015-2020)
6.3 Japan Liraglutide Sales Market Share by Type (2015-2020)
6.4 Japan Liraglutide Sales Market Share by Application (2015-2020)
7 Southeast Asia Liraglutide Market Facts & Figures
7.2 Southeast Asia Liraglutide Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Liraglutide Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Liraglutide Sales Market Share by Application (2015-2020)
8 India Liraglutide Market Facts & Figures
8.2 India Liraglutide Sales Market Share by Company (2015-2020)
8.3 India Liraglutide Sales Market Share by Type (2015-2020)
8.4 India Liraglutide Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Liraglutide Business
12.1 HEC Pharm
12.1.1 HEC Pharm Liraglutide Corporation Information
12.1.2 HEC Pharm Liraglutide Business Overview and Total Revenue
12.1.3 HEC Pharm Liraglutide Sales, Revenue and Gross Margin (2015-2020)
12.1.4 HEC Pharm Liraglutide Products Offered
12.1.5 HEC Pharm Recent Development
12.2 Bachem
12.2.1 Bachem Liraglutide Corporation Information
12.2.2 Bachem Liraglutide Business Overview and Total Revenue
12.2.3 Bachem Liraglutide Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bachem Liraglutide Products Offered
12.2.5 Bachem Recent Development
12.3 Bharat Pharmaceuticals
12.3.1 Bharat Pharmaceuticals Liraglutide Corporation Information
12.3.2 Bharat Pharmaceuticals Liraglutide Business Overview and Total Revenue
12.3.3 Bharat Pharmaceuticals Liraglutide Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bharat Pharmaceuticals Liraglutide Products Offered
12.3.5 Bharat Pharmaceuticals Recent Development
12.4 Kingpep Biotechnology
12.4.1 Kingpep Biotechnology Liraglutide Corporation Information
12.4.2 Kingpep Biotechnology Liraglutide Business Overview and Total Revenue
12.4.3 Kingpep Biotechnology Liraglutide Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Kingpep Biotechnology Liraglutide Products Offered
12.4.5 Kingpep Biotechnology Recent Development
12.5 Shenzhen JYMed Technology
12.5.1 Shenzhen JYMed Technology Liraglutide Corporation Information
12.5.2 Shenzhen JYMed Technology Liraglutide Business Overview and Total Revenue
12.5.3 Shenzhen JYMed Technology Liraglutide Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Shenzhen JYMed Technology Liraglutide Products Offered
12.5.5 Shenzhen JYMed Technology Recent Development
12.6 Wuxi Asiapeptide
12.6.1 Wuxi Asiapeptide Liraglutide Corporation Information
12.6.2 Wuxi Asiapeptide Liraglutide Business Overview and Total Revenue
12.6.3 Wuxi Asiapeptide Liraglutide Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Wuxi Asiapeptide Liraglutide Products Offered
12.6.5 Wuxi Asiapeptide Recent Development
12.7 AmbioPharm
12.7.1 AmbioPharm Liraglutide Corporation Information
12.7.2 AmbioPharm Liraglutide Business Overview and Total Revenue
12.7.3 AmbioPharm Liraglutide Sales, Revenue and Gross Margin (2015-2020)
12.7.4 AmbioPharm Liraglutide Products Offered
12.7.5 AmbioPharm Recent Development
…
13 Liraglutide Manufacturing Cost Analysis
13.1 Liraglutide Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Liraglutide
13.4 Liraglutide Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Liraglutide Distributors List
14.3 Liraglutide Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Liraglutide Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Liraglutide Sales (K MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Liraglutide Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Liraglutide Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Liraglutide Players to Combat Covid-19 Impact
Table 8. Global Market Liraglutide Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Liraglutide Sales (K MT) by Region (2015-2020)
Table 10. Global Liraglutide Sales Market Share by Region (2015-2020)
Table 11. Global Liraglutide Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Liraglutide Revenue Share by Region (2015-2020)
Table 13. Global Liraglutide Sales (K MT) Forecast by Region (2021-2026)
Table 14. Global Liraglutide Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Liraglutide Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Liraglutide Revenue Share Forecast by Region (2021-2026)
Table 17. Global Liraglutide (K MT) of Key Companies (2015-2020)
Table 18. Global Liraglutide Sales Share by Company (2015-2020)
Table 19. Global Liraglutide Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Liraglutide Revenue Share by Company (2015-2020)
Table 21. Global Liraglutide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liraglutide as of 2019)
Table 22. Global Liraglutide Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Liraglutide Manufacturing Sites and Area Served
Table 24. Manufacturers Liraglutide Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Liraglutide Players
Table 27. Global Liraglutide Sales (K MT) by Type (2015-2020)
Table 28. Global Liraglutide Sales Share by Type (2015-2020)
Table 29. Global Liraglutide Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Liraglutide Price (K MT) by Type (2015-2020)
Table 31. Global Liraglutide Sales Share by Type (2021-2026)
Table 32. Global Liraglutide Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Liraglutide Revenue Share by Type (2021-2026)
Table 34. Global Liraglutide Price (K MT) by Type (2021-2026)
Table 35. Global Liraglutide Sales (K MT) by Application (2015-2020)
Table 36. Global Liraglutide Sales Share by Application (2015-2020)
Table 37. Global Liraglutide Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Liraglutide Price (K MT) by Application (2015-2020)
Table 39. Global Liraglutide Sales (K MT) by Application (2021-2026)
Table 40. Global Liraglutide Sales Share by Application (2021-2026)
Table 41. Global Liraglutide Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Liraglutide Revenue Share by Application (2021-2026)
Table 43. Global Liraglutide Price (K MT) by Application (2021-2026)
Table 44. United States Liraglutide Sales (K MT) by Company (2015-2020)
Table 45. United States Liraglutide Sales Market Share by Company (2015-2020)
Table 46. United States Liraglutide Sales (K MT) by Type (2015-2020)
Table 47. United States Liraglutide Sales Market Share by Type (2015-2020)
Table 48. United States Liraglutide Sales (K MT) by Application (2015-2020)
Table 49. United States Liraglutide Sales Market Share by Application (2015-2020)
Table 50. Europe Liraglutide Sales (K MT) by Company (2015-2020)
Table 51. Europe Liraglutide Sales Market Share by Company (2015-2020)
Table 52. Europe Liraglutide Sales (K MT) by Type (2015-2020)
Table 53. Europe Liraglutide Sales Market Share by Type (2015-2020)
Table 54. Europe Liraglutide Sales (K MT) by Application (2015-2020)
Table 55. Europe Liraglutide Sales Market Share by Type (2015-2020)
Table 56. China Liraglutide Sales (K MT) by Company (2015-2020)
Table 57. China Liraglutide Sales Market Share by Company (2015-2020)
Table 58. China Liraglutide Sales (K MT) by Type (2015-2020)
Table 59. China Liraglutide Sales Market Share by Type (2015-2020)
Table 60. China Liraglutide Sales (K MT) by Application (2015-2020)
Table 61. China Liraglutide Sales Market Share by Application (2015-2020)
Table 62. Japan Liraglutide Sales (K MT) by Company (2015-2020)
Table 63. Japan Liraglutide Sales Market Share by Company (2015-2020)
Table 64. Japan Liraglutide Sales (K MT) by Type (2015-2020)
Table 65. Japan Liraglutide Sales Market Share by Type (2015-2020)
Table 66. Japan Liraglutide Sales (K MT) by Application (2015-2020)
Table 67. Japan Liraglutide Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Liraglutide Sales (K MT) by Company (2015-2020)
Table 69. Southeast Asia Liraglutide Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Liraglutide Sales (K MT) by Type (2015-2020)
Table 71. Southeast Asia Liraglutide Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Liraglutide Sales (K MT) by Type (2015-2020)
Table 73. Southeast Asia Liraglutide Sales Market Share by Application (2015-2020)
Table 74. India Liraglutide Sales (K MT) by Company (2015-2020)
Table 75. India Liraglutide Sales Market Share by Company (2015-2020)
Table 76. India Liraglutide Sales (K MT) by Type (2015-2020)
Table 77. India Liraglutide Sales Market Share by Type (2015-2020)
Table 78. India Liraglutide Sales (K MT) by Application (2015-2020)
Table 79. India Liraglutide Sales Market Share by Application (2015-2020)
Table 80. HEC Pharm Corporation Information
Table 81. HEC Pharm Description and Business Overview
Table 82. HEC Pharm Liraglutide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. HEC Pharm Liraglutide Product
Table 84. HEC Pharm Recent Development
Table 85. Bachem Corporation Information
Table 86. Bachem Description and Business Overview
Table 87. Bachem Liraglutide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Bachem Liraglutide Product
Table 89. Bachem Recent Development
Table 90. Bharat Pharmaceuticals Corporation Information
Table 91. Bharat Pharmaceuticals Description and Business Overview
Table 92. Bharat Pharmaceuticals Liraglutide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Bharat Pharmaceuticals Liraglutide Product
Table 94. Bharat Pharmaceuticals Recent Development
Table 95. Kingpep Biotechnology Corporation Information
Table 96. Kingpep Biotechnology Description and Business Overview
Table 97. Kingpep Biotechnology Liraglutide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Kingpep Biotechnology Liraglutide Product
Table 99. Kingpep Biotechnology Recent Development
Table 100. Shenzhen JYMed Technology Corporation Information
Table 101. Shenzhen JYMed Technology Description and Business Overview
Table 102. Shenzhen JYMed Technology Liraglutide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Shenzhen JYMed Technology Liraglutide Product
Table 104. Shenzhen JYMed Technology Recent Development
Table 105. Wuxi Asiapeptide Corporation Information
Table 106. Wuxi Asiapeptide Description and Business Overview
Table 107. Wuxi Asiapeptide Liraglutide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Wuxi Asiapeptide Liraglutide Product
Table 109. Wuxi Asiapeptide Recent Development
Table . AmbioPharm Corporation Information
Table . AmbioPharm Description and Business Overview
Table . AmbioPharm Liraglutide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . AmbioPharm Liraglutide Product
Table . AmbioPharm Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Liraglutide Distributors List
Table 118. Liraglutide Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Liraglutide Product Picture
Figure 2. Global Liraglutide Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Liraglutide Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Drug Store Examples
Figure 8. Global Liraglutide Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Liraglutide Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Liraglutide Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Liraglutide Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Liraglutide Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Liraglutide Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Liraglutide Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Liraglutide Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Liraglutide Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Liraglutide Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Liraglutide Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Liraglutide Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Liraglutide Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Liraglutide Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Liraglutide Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Liraglutide Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Liraglutide Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Liraglutide Players Market Share by Revenue in Liraglutide 2015 & 2019
Figure 26. Liraglutide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Liraglutide Revenue Share by Type (2015-2020)
Figure 28. Global Liraglutide Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Liraglutide Revenue Share by Application (2015-2020)
Figure 30. Global Liraglutide Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Liraglutide Sales Market Share by Type in 2019
Figure 32. United States Liraglutide Sales Market Share by Type in 2019
Figure 33. Europe Liraglutide Sales Market Share by Company in 2019
Figure 34. Europe Liraglutide Sales Market Share by Type in 2019
Figure 35. Europe Liraglutide Sales Market Share by Application in 2019
Figure 36. China Liraglutide Sales Market Share by Company in 2019
Figure 37. China Liraglutide Sales Market Share by Type in 2019
Figure 38. China Liraglutide Sales Market Share by Application in 2019
Figure 39. Japan Liraglutide Sales Market Share by Company in 2019
Figure 40. Japan Liraglutide Sales Market Share by Type in 2019
Figure 41. Japan Liraglutide Sales Market Share by Application in 2019
Figure 42. Southeast Asia Liraglutide Sales Market Share by Company in 2019
Figure 43. Southeast Asia Liraglutide Sales Market Share by Type in 2019
Figure 44. Southeast Asia Liraglutide Sales Market Share by Application in 2019
Figure 45. India Liraglutide Sales Market Share by Company in 2019
Figure 46. India Liraglutide Sales Market Share by Type in 2019
Figure 47. India Liraglutide Sales Market Share by Application in 2019
Figure 48. HEC Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Bachem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Bharat Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Kingpep Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Shenzhen JYMed Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Wuxi Asiapeptide Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. AmbioPharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Liraglutide
Figure 57. Manufacturing Process Analysis of Liraglutide
Figure 58. Liraglutide Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
リラグルチド薬の世界市場レポート2020 A recently published report by QY Research titled Global Liraglutide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …- GLPアナログの世界市場レポート2020 A recently published report by QY Research titled Global GLP Analogs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data i…
- 象皮病薬の世界市場レポート2020 Market Analysis and Insights: Global Elephantiasis Drug Market The global Elephantiasis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Elephantiasis Drug Scope and Market Size The global Elephantias…
- フィブリノーゲン欠乏症薬の世界市場レポート2020 Market Analysis and Insights: Global Fibrinogen Deficiency Drug Market The global Fibrinogen Deficiency Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Fibrinogen Deficiency Drug Scope and Market Siz…
- アレルギー鼻炎薬の世界市場レポート2020 Market Analysis and Insights: Global Allergy Rhinitis Drug Market The global Allergy Rhinitis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Allergy Rhinitis Drug Scope and Market Size The global Al…